Tryptamine compounds, and methods of cerebrovascular treatment therewith
    4.
    发明授权
    Tryptamine compounds, and methods of cerebrovascular treatment therewith 失效
    色胺化合物,以及脑血管治疗方法

    公开(公告)号:US4980368A

    公开(公告)日:1990-12-25

    申请号:US946387

    申请日:1986-12-23

    CPC分类号: C07D209/42 C07D209/16

    摘要: A compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein: R.sub.1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or halogen;R.sub.2 and R.sub.3 are both hydrogen or together represent a bond;R.sub.4 is selected from C.sub.1-6 alkyl, phenyl, phenyl C.sub.1-4 alkyl, COR.sub.8 where R.sub.8 is hydroxy, C.sub.1-6 alkoxy or NR.sub.9 R.sub.10 where R.sub.9 and R.sub.10 are independently hydrogen or C.sub.1-4 alkyl and CH.sub.2 OR.sub.11 and R.sub.11 is hydrogen, C.sub.1-4 alkyl or C.sub.1-4 alkanoyl;R.sub.5 is hydrogen, C.sub.1-6 alkyl or phenyl C.sub.1-4 alkyl;R.sub.6 is phenyl C.sub.1-7 alkyl in which the phenyl moiety is optionally substituted by one or two of halogen, ortho-nitro, meta- or para-methoxy, methyl or NR.sub.12 R.sub.13 wherein R.sub.12 and R.sub.13 are independently hydrogen or C.sub.1-6 alkyl or R.sub.12 and R.sub.13 together are C.sub.2-6 polymethylene or the phenyl moiety is 3,4-disubstituted by methylenedioxy or ethylenedioxy; andR.sub.7 is hydrogen or C.sub.1-4 alkyl, processes for its preparation and its use as a pharmaceutical.

    摘要翻译: 式(I)化合物或其药学上可接受的盐:其中:R 1是氢,C 1-6烷基,C 1-6烷氧基或卤素; R2和R3都是氢或一起代表键; R4选自C1-6烷基,苯基,苯基C1-4烷基,COR8,其中R8是羟基,C1-6烷氧基或NR9R10,其中R9和R10独立地是氢或C1-4烷基,CH2OR11和R11是氢,C1- 4烷基或C 1-4烷酰基; R5是氢,C1-6烷基或苯基C1-4烷基; R6是苯基C1-7烷基,其中苯基部分任选被一个或两个卤素,邻硝基,间位或对甲氧基,甲基或NR12R13取代,其中R12和R13独立地是氢或C1-6烷基或R12 和R 13一起是C2-6聚亚甲基或苯基部分被亚甲二氧基或亚乙二氧基3,4-二取代; 并且R 7是氢或C 1-4烷基,其制备及其用作药物的方法。